{"slideshow_credits": null, "snippet": "In Switzerland, the first controlled trial of the drug in more than 40 years found that it eased anxiety in people nearing the end of their lives.", "abstract": "Journal of Nervous and Mental Disease is publishing results from first controlled trial of LSD in more than 40 years; publication marks latest in series of baby steps by loose coalition of researchers and fund-raisers working to bring hallucinogens, which were banned in United States in 1966, back into fold of mainstream psychiatry; of particular interest is possibility of drug's use in controlling end-of-life anxiety.", "section_name": "Health", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Benedict", "role": "reported", "lastname": "CAREY", "rank": 1, "organization": ""}], "original": "By BENEDICT CAREY", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/03/04/health/lsd-reconsidered-for-therapy.html", "lead_paragraph": "In Switzerland, the first controlled trial of the drug in more than 40 years found that it eased anxiety in people nearing the end of their lives.", "headline": {"main": "LSD, Reconsidered for Therapy", "print_headline": "LSD, Reconsidered for Therapy"}, "_id": "5314f09738f0d8790619c0c5", "word_count": "906", "multimedia": [{"height": 126, "url": "images/2014/03/04/science/04LSD_SPAN/04LSD-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/03/04/science/04LSD_SPAN/04LSD-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 269, "url": "images/2014/03/04/science/04LSD_SPAN/04LSD-articleLarge.jpg", "legacy": {"xlarge": "images/2014/03/04/science/04LSD_SPAN/04LSD-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "269"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/03/04/science/04LSD_SPAN/04LSD-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/03/04/science/04LSD_SPAN/04LSD-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-03-04T00:00:00Z", "source": "The New York Times", "news_desk": "Science", "keywords": [{"value": "Journal of Nervous and Mental Disease", "name": "organizations", "is_major": "Y", "rank": "5"}, {"value": "Anxiety and Stress", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Mental Health and Disorders", "name": "subject", "is_major": "Y", "rank": "6"}, {"value": "LSD (Lysergic Acid Diethylamide)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Therapy and Rehabilitation", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Psychiatry and Psychiatrists", "name": "subject", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}